Semler Scientific (SMLR) Competitors

LeMaitre Vascular (NASDAQ:LMAT) and Semler Scientific (NASDAQ:SMLR) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, valuation, earnings, analyst recommendations, institutional ownership and profitability.

Which has more risk and volatility, LMAT or SMLR?

LeMaitre Vascular has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500.

Do institutionals & insiders hold more shares of LMAT or SMLR?

84.6% of LeMaitre Vascular shares are held by institutional investors. Comparatively, 49.4% of Semler Scientific shares are held by institutional investors. 9.5% of LeMaitre Vascular shares are held by company insiders. Comparatively, 16.4% of Semler Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Do analysts recommend LMAT or SMLR?

LeMaitre Vascular presently has a consensus price target of $98.00, suggesting a potential upside of 5.20%. Semler Scientific has a consensus price target of $81.75, suggesting a potential upside of 132.87%. Given Semler Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Semler Scientific is more favorable than LeMaitre Vascular.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Semler Scientific	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25

Does the media refer more to LMAT or SMLR?

In the previous week, LeMaitre Vascular had 29 more articles in the media than Semler Scientific. MarketBeat recorded 40 mentions for LeMaitre Vascular and 11 mentions for Semler Scientific. LeMaitre Vascular's average media sentiment score of 0.78 beat Semler Scientific's score of 0.23 indicating that LeMaitre Vascular is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LeMaitre Vascular	10 Very Positive mention(s)	2 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Semler Scientific	0 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has stronger valuation and earnings, LMAT or SMLR?

LeMaitre Vascular has higher revenue and earnings than Semler Scientific. Semler Scientific is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$219.86M	9.59	$44.04M	$2.06	45.22
Semler Scientific	$56.29M	9.24	$40.90M	$2.43	14.45

Is LMAT or SMLR more profitable?

Semler Scientific has a net margin of 86.20% compared to LeMaitre Vascular's net margin of 20.08%. Semler Scientific's return on equity of 43.84% beat LeMaitre Vascular's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	20.08%	13.67%	9.14%
Semler Scientific	86.20%	43.84%	32.88%

Summary

Semler Scientific beats LeMaitre Vascular on 9 of the 16 factors compared between the two stocks.